17-76002392-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001258.4(CDK3):c.460G>A(p.Val154Met) variant causes a missense change. The variant allele was found at a frequency of 0.000314 in 1,612,476 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )
Consequence
CDK3
NM_001258.4 missense
NM_001258.4 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 6.84
Genes affected
CDK3 (HGNC:1772): (cyclin dependent kinase 3) This gene encodes a member of the cyclin-dependent protein kinase family. The protein promotes entry into S phase, in part by activating members of the E2F family of transcription factors. The protein also associates with cyclin C and phosphorylates the retinoblastoma 1 protein to promote exit from G0. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023290426).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK3 | NM_001258.4 | c.460G>A | p.Val154Met | missense_variant | 5/8 | ENST00000448471.3 | NP_001249.1 | |
TEN1-CDK3 | NR_037709.1 | n.2296G>A | non_coding_transcript_exon_variant | 7/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK3 | ENST00000448471.3 | c.460G>A | p.Val154Met | missense_variant | 5/8 | 5 | NM_001258.4 | ENSP00000400088 | P1 | |
CDK3 | ENST00000425876.6 | c.460G>A | p.Val154Met | missense_variant | 4/7 | 1 | ENSP00000410561 | P1 | ||
CDK3 | ENST00000586261.2 | c.340G>A | p.Val114Met | missense_variant | 3/5 | 5 | ENSP00000465062 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152050Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
48
AN:
152050
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000368 AC: 92AN: 249920Hom.: 1 AF XY: 0.000400 AC XY: 54AN XY: 135158
GnomAD3 exomes
AF:
AC:
92
AN:
249920
Hom.:
AF XY:
AC XY:
54
AN XY:
135158
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000314 AC: 459AN: 1460308Hom.: 1 Cov.: 32 AF XY: 0.000310 AC XY: 225AN XY: 726464
GnomAD4 exome
AF:
AC:
459
AN:
1460308
Hom.:
Cov.:
32
AF XY:
AC XY:
225
AN XY:
726464
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000315 AC: 48AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74410
GnomAD4 genome
AF:
AC:
48
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
51
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.460G>A (p.V154M) alteration is located in exon 5 (coding exon 4) of the CDK3 gene. This alteration results from a G to A substitution at nucleotide position 460, causing the valine (V) at amino acid position 154 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.
REVEL
Uncertain
Sift
Uncertain
.;D;D;.
Sift4G
Uncertain
D;D;D;D
Polyphen
0.97
.;D;D;.
Vest4
0.80
MVP
MPC
0.89
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at